Factors associated with medication adherence in patients with chronic obstructive pulmonary disease

Respiration

Volumn 82, Issue 4, 2011, Pages 328-334

  Agh, Tamas ^a   Inotai, Andras ^a   Meszaros, Agnes ^a  

^a SEMMELWEIS UNIVERSITY   (Hungary)

Author keywords

Chronic obstructive pulmonary disease; Medication adherence; Quality of life; Respiratory therapy

Indexed keywords

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CROSS-SECTIONAL STUDY; DISEASE SEVERITY; DRUG COST; FEMALE; FORCED EXPIRATORY VOLUME; GENDER; HUMAN; LUNG FUNCTION; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; OUTPATIENT; PATIENT COMPLIANCE; PREDICTION; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; SMOKING;

BRONCHODILATOR AGENTS; CROSS-SECTIONAL STUDIES; FEMALE; FORCED EXPIRATORY VOLUME; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; HUNGARY; LOGISTIC MODELS; MALE; MEDICATION ADHERENCE; MIDDLE AGED; MULTIVARIATE ANALYSIS; OUTPATIENTS; PREDICTIVE VALUE OF TESTS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; QUALITY OF LIFE; QUESTIONNAIRES; RISK FACTORS; SELF CARE; SEVERITY OF ILLNESS INDEX; SMOKING;

EID: 80052961455     PISSN: 00257931     EISSN: 14230356     Source Type: Journal    
DOI: 10.1159/000324453     Document Type: Article

References (34)

1. Viegi G, Scognamiglio A, Baldacci S, Pistelli F, Carrozzi L: Epidemiology of chronic obstructive pulmonary disease (COPD). Respiration 2001;68:4-19. (Pubitemid 32172948)
2. Holguin F, Folch E, Redd SC, Mannino DM: Comorbidity and mortality in COPD-related hospitalizations in the United States, 1979 to 2001. Chest 2005;128:2005-2011. (Pubitemid 41507534)
3. Rabe KF, Hurd S, Anzueto A, Barnes PJ, Buist SA, Calverley P, Fukuchi Y, Jenkins C, Rodriguez-Roisin R, van Weel C, Zielinski J: Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 2007;176:532-555. (Pubitemid 47403272)
4. Revicki DA, Frank L: Pharmacoeconomic evaluation in the real world: effectiveness versus efficacy studies. Pharmacoeconomics 1999;15:423-434. (Pubitemid 29210946)
5. Rand CS, Nides M, Cowles MK, Wise RA, Connett J: Long-term metered-dose inhaler adherence in aclinica ltrial. The Lung Hea lth Study Research Group. Am J Respir Crit Care Med 1995;152:580-588.
6. Kesten S, Flanders J, Serby CW and Witek TJ: Compliance with tiotropium, a once daily dry powder inhaled bronchodilator, in one year COPD trials. Chest 2000;118:191S-192S.
7. van Grunsven PM, van Schayck CP, van Deuveren M, van Herwaarden CL, Akkermans RP, van Weel C: Compliance during long-term treatment with fluticasone propionate in subjects with early signs of asthma or chronic obstructive pulmonary disease (COPD): results of the Detection, Intervention, and Monitoring Program of COPD and Ast hma (DIMCA) Study. J Asthma 2000;37:225-234. (Pubitemid 30314294)
8. Krigsman K, Nilsson JL, Ring L: Refill adherence for patients with asthma and COPD: comparison of a pharmacy record database with manually collected repeat prescriptions. Pharmacoepidemiol Drug Saf 2007;16:441-448. (Pubitemid 46656866)
9. Dolce JJ, Crisp C, Manzella B, Richards JM, Hardin JM, Bailey WC: Medication adherence patterns in chronic obstructive pulmonary disease. Chest 1991;99:837-841.
10. Bosley CM, Parry DT, Cochrane GM: Patient compliance with inhaled medication. Does combining beta agonists with corticosteroids improve compliance? Eur Respir J 1994;7:504-509. (Pubitemid 24099012)
11. Bourbeau J, Bartlett SJ: Patient adherence in COPD. Thora x 2008;63:831-838.
12. Regueiro CR, Hamel MB, Davis RB, Desbiens N, Connors AF Jr, Phillips RS: A comparison of generalist and pulmonologist care for patients hospitalized with severe chronic obstructive pulmonary disease: resource intensity, hospital costs, and survival. Am J Med 1998;105:366-372. (Pubitemid 28536220)
13. Osthoff M, Leuppi JD: Management of chronic obstructive pulmonary disease patients after hospitalization for acute exacerbation. Respiration 2010;79:255-261.
14. World Health Organization: Adherence to Long-Term Therapies: Evidence for Action. Geneva, World Health Organization, 2003, pp 1-45.
15. Baiardini I, Braido F, Bonini M, Compalati E, Canonica GW: Why do doctors and patients not follow guidelines? Curr Opin Allergy Clin Immunol 2009;9:228-233.
16. Restrepo RD, Alvarez MT, Wittnebel LD, Sorenson H, Wettstein R, Vines DL, Sikkema-Ortiz J, Gardner DD, Wilkins RL: Medication adherence issues in patients treated for COPD. Int J Chron Obstruct Pulmon Dis 2008;3:371-384.
17. Breekveldt-Postma NS, Gerrits CM, Lammers JW, Raaijmakers JA, Herings RM: Persistence with inhaled corticosteroid therapy in da ily practice. Respir Med 2004;98:752-759. (Pubitemid 38842778)
18. Turner J, Wright E, Mendella L, Anthonisen N: Predictors of patient adherence to longterm home nebulizer therapy for COPD. Chest 1995;108:394-400.
19. Cleemput I, Kesteloot K, DeGeest S: A review of the literature on the economics of noncompliance. Room for methodological improvement. Hea lth Policy 2002;59:65-94.
20. Morisky DE, Green LW, Levine DM: Concurrent and predictive validity of a self-reported measure of medication adherence. Med Care 1986;24:67-74. (Pubitemid 16125389)
21. Dolan P, Gudex C: Time preference, duration and health state valuations. Health Econ 1995;4:289-299.
22. Rutten-van Molken MP, Oostenbrink JB, Tashkin DP, Burkhart D, Monz BU: Does quality of life of COPD patients as measured by the generic EuroQol five-dimension questionnaire differentiate between COPD severity stages? Chest 2006;130:1117-1128. (Pubitemid 44583743)
23. Pharmindex. Budapest, CMP Medica, 2009.
24. Corden ZM, Bosley CM, Rees PJ, Cochrane GM: Home nebulized therapy for patients with COPD: patient compliance with treatment and its relation to quality of life. Chest 1997;112:1278-1282. (Pubitemid 27497859)
25. Apter AJ, Reisine ST, Affleck G, Barrows E, ZuWallack RL: Adherence with twice-daily dosing of inhaled steroids. Socioeconomic and health-belief differences. Am J Respir Crit Care Med 1998;157:1810-1817.
26. Laforest L, Denis F, Van Ganse E, Ritleng C, Saussier C, Passante N, Devouassoux G, Chatte G, Freymond N, Pacheco Y: Correlates of adherence to respiratory drugs in COPD patients. Prim Care Respir J 2010;19:148-154.
27. Breekveldt-Postma NS, Koerselman J, Erkens JA, Lammers JW, Herings RM: Enhanced persistence with tiotropium compared with other respiratory drugs in COPD. Respir Med 2007;101:1398-1405. (Pubitemid 46832237)
28. Jung E, Pickard AS, Salmon JW, Bartle B, Lee TA: Medication adherence and persistence in the last year of life in COPD patients. Respir Med 2009;103:525-534.
29. Cramer JA, Bradley-Kennedy C, Scalera A: Treatment persistence and compliance with medications for chronic obstructive pulmonary disease. Can Respir J 2007;14:25-29. (Pubitemid 46637657)
30. Hughes CM: Medication non-adherence in the elderly: how big is the problem? Drugs Aging 2004;21:793-811. (Pubitemid 39423335)
31. Soumerai SB, Ross-Degnan D, Avorn J, McLaughlin T, Choodnovskiy I: Effects of Medicaid drug-payment li m its on admission to hospitals and nursing homes. N Engl J Med 1991;325:1072-1077.
32. Jones PW: Issues concerning health-related quality of life in COPD. Chest 1995;107:187S-193S.
33. Cote I, Farris K, Feeny D: Is adherence to drug treatment correlated with health-related qua lity of life? Qual Life Res 2003;12:621-633. (Pubitemid 37094026)
34. Santiveri C, Espinalt M, Diaz Carrasco FX, Marin A, Miguel E, Jones PW: Evaluation of male COPD patients' health status by proxies. Respir Med 2007;101:439-445. (Pubitemid 46205910)